Role of microRNAs in drug-resistant ovarian cancer cells (Q39934697)

15 September 2017

Role of microRNAs in drug-resistant ovarian cancer cells (English)

1 reference

15 September 2017

1 reference

1 reference

5

Giovanni Scambia

1 reference

15 September 2017

Antonio Sorrentino

1

1 reference

15 September 2017

Chang-Gong Liu

2

1 reference

15 September 2017

Antonio Addario

3

1 reference

15 September 2017

Cesare Peschle

4

1 reference

15 September 2017

Cristiano Ferlini

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

26 September 2008

1 reference

15 September 2017

1 reference

15 September 2017

111

1 reference

15 September 2017

478-486

1 reference

15 September 2017

3

1 reference

Biological characterization of ovarian cancer: prognostic and therapeutic implications

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Role of chemotherapy in the management of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Molecular mechanisms of resistance and toxicity associated with platinating agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

The diverse functions of microRNAs in animal development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

The transcriptional landscape of the mammalian genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

miRNAs, cancer, and stem cell division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

MicroRNA gene expression deregulation in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

The role of microRNA genes in papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

MicroRNA signatures in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

miRNA genetic alterations in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Role of miRNA in carcinogenesis and biomarker selection: a methodological view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Roles of microRNAs and their targets in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Prediction of mammalian microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Combinatorial microRNA target predictions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Colony-stimulating factor-1 in immunity and inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Let-7 expression defines two differentiation stages of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Endogenous human microRNAs that suppress breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Genomic signatures to guide the use of chemotherapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

Short interfering RNA (siRNA) as a novel therapeutic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.017

10.1016/J.YGYNO.2008.08.017

7 January 2021

Identifiers

DOI

1 reference

release_fsiyct3cqjfvfcetoukrgafre4

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fsiyct3cqjfvfcetoukrgafre4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference